A technology evaluation of CVT-301 (Inbrija): an inhalable therapy for treatment of Parkinson’s disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A technology evaluation of CVT-301 (Inbrija): an inhalable therapy for treatment of Parkinson’s disease

Published:2021-09-10 Issue:11 Volume:18 Page:1559-1569
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Lipp Michael M.¹,Hickey Anthony J.²,Langer Robert³,LeWitt Peter A.⁴

Affiliation:

1. Acorda Therapeutics, Ardsley, NY, USA

2. RTI International, Research Triangle Park, NC, USA

3. Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA

4. Department of Neurology, Henry Ford Hospital and Wayne State University School of Medicine, West Bloomfield, MI, USA

Funder

Acorda Therapeutics

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2021.1960820

Reference55 articles.

1. Levodopa for the Treatment of Parkinson's Disease

2. Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics

3. Gastrointestinal dysfunction in Parkinson's disease

4. Clinical implications of gastric complications on levodopa treatment in Parkinson's disease

5. Gastroparesis and Parkinson’s disease: A systematic review

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intranasal Administration of Bedaquiline-Loaded Fucosylated Liposomes Provides Anti-Tubercular Activity while Reducing the Potential for Systemic Side Effects;ACS Infectious Diseases;2024-08-13

2. 3D-printed solid oral dosage forms for mental and neurological disorders: recent advances and future perspectives;Expert Opinion on Drug Delivery;2023-12-11

3. Clinical Use of On-Demand Therapies for Patients with Parkinson’s Disease and OFF Periods;Neurology and Therapy;2023-05-23

4. Inhaled levodopa for threatening impending OFF episodes in managing Parkinson’s disease;Journal of Neural Transmission;2023-04-23

5. The Clinical Development of Levodopa Inhalation Powder;Clinical Neuropharmacology;2023-01-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3